Jury nixes Momenta patent case that sought $938M in damages
July 21, 2017 at 14:41 PM EDT
The case stemmed from the Cambridge drugmaker's partnership with Sandoz to develop a generic version of the blood-thinner, Lovenox.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|